AU2003239092A1 - Methods for identifying novel transcription inhibitors - Google Patents

Methods for identifying novel transcription inhibitors

Info

Publication number
AU2003239092A1
AU2003239092A1 AU2003239092A AU2003239092A AU2003239092A1 AU 2003239092 A1 AU2003239092 A1 AU 2003239092A1 AU 2003239092 A AU2003239092 A AU 2003239092A AU 2003239092 A AU2003239092 A AU 2003239092A AU 2003239092 A1 AU2003239092 A1 AU 2003239092A1
Authority
AU
Australia
Prior art keywords
methods
identifying novel
transcription inhibitors
novel transcription
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003239092A
Inventor
Bertil Daneholt
Nathalie Fomproix
Francesc Miralles
Piergiorgio Percipalle
Neus Visa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIDEC TECHNOLOGIES AB
Original Assignee
SIDEC TECHNOLOGIES AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0202007A external-priority patent/SE0202007D0/en
Application filed by SIDEC TECHNOLOGIES AB filed Critical SIDEC TECHNOLOGIES AB
Publication of AU2003239092A1 publication Critical patent/AU2003239092A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003239092A 2002-06-27 2003-06-26 Methods for identifying novel transcription inhibitors Abandoned AU2003239092A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39210002P 2002-06-27 2002-06-27
SE0202007A SE0202007D0 (en) 2002-06-27 2002-06-27 New compound
US60/392,100 2002-06-27
SE0202007-1 2002-06-27
PCT/SE2003/001112 WO2004003553A1 (en) 2002-06-27 2003-06-26 Methods for identifying novel transcription inhibitors

Publications (1)

Publication Number Publication Date
AU2003239092A1 true AU2003239092A1 (en) 2004-01-19

Family

ID=30002444

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003239092A Abandoned AU2003239092A1 (en) 2002-06-27 2003-06-26 Methods for identifying novel transcription inhibitors

Country Status (2)

Country Link
AU (1) AU2003239092A1 (en)
WO (1) WO2004003553A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005036333A1 (en) * 2005-07-29 2007-02-01 Eckart Gmbh & Co. Kg Cosmetic composition, especially nail varnish, comprising a liquid phase and an aluminum pigment produced by physical vapor deposition includes a leafing additive

Also Published As

Publication number Publication date
WO2004003553A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003214850A1 (en) Method for determining media qualities
AU2003303483A1 (en) Ccr8 inhibitors
AU2002353108A1 (en) Method for determining location information
AU2003281351A1 (en) Substituted 3-cyanoquinolines as mek inhibitors
EP1585970A3 (en) Methods for separating molecules
AU2003218039A1 (en) Method for reduced methanation
AU2003256783A1 (en) METHODS FOR IMPROVEMENT OF LUNG FUNCTION USING TGF-Beta INHIBITORS
AU2003206898A1 (en) Method for rate matching
AU2003299883A1 (en) Ccr8 inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003255952A1 (en) Oxytocin inhibitors
EP1348567B8 (en) Recording apparatus
AU2003302588A1 (en) Phosphodiesterase 10a inhibitors
AU2003256995A1 (en) Method for identifying cancer risk
AU2003299901A1 (en) Thrombin inhibitors
AU2002349976A1 (en) Methods for predicting transcription levels
AU2003202205A1 (en) Methods for identifying cancer risk
AU2003269984A1 (en) Protease inhibitors
AU2003256323A1 (en) Sos1 inhibitors
AU2003900325A0 (en) Identifying apparatus
AU2003274248A1 (en) Method for communicating structured information
AU2003275829A1 (en) Method for information retrieval
AU2003263129A1 (en) Laser-supported reproduction method
AU2002305789A1 (en) Method for detecting transcription factor-protein interactions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase